<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35097">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01840020</url>
  </required_header>
  <id_info>
    <org_study_id>2012/1206</org_study_id>
    <nct_id>NCT01840020</nct_id>
  </id_info>
  <brief_title>Bariatric Surgery and Alcohol Metabolism</brief_title>
  <official_title>Changes in Bioavailability of Ethanol Following Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The first-pass metabolism (FPM) is a barrier to the toxicity of ethanol. Changes to the size
      and function of the stomach may alter FPM. Bariatric surgery, like the gastric bypass
      procedure, involves significant changes to the size and function of the stomach and leads to
      more rapid gastric emptying. Consequences will be faster absorption and higher peak
      concentration of ethanol after surgery than before. There are growing concerns that surgery
      for obesity in this way may cause alcohol abuse.

      In this study the investigators compare changes in FPM of ethanol following two different
      bariatric surgical procedures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change in bioavailability of ethanol</measure>
    <time_frame>from baseline to 3 months, 1 year, and 3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>bioavailability tests: Plasma concentration of ethanol. Calculation:
Area under curve (AUC)
Maximum concentration(Cmax)
Time up to maximum concentration (tmax)
Oral bioavailability (AUCpo/AUCiv)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obesity, Morbid</condition>
  <arm_group>
    <arm_group_label>Gastric bypass</arm_group_label>
    <description>patients recruited from Central Norway</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gastric sleeve</arm_group_label>
    <description>patients recruited from Central Norway</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gastric bypass</intervention_name>
    <description>Surgical procedure in which the stomach is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the small intestine by an end-to-side surgical anastomosis.</description>
    <arm_group_label>Gastric bypass</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>gastric sleeve</intervention_name>
    <description>Sleeve gastrectomy, a surgical procedure in which the stomach is reduced to about 25% of its original size, by surgical removal of a large portion of the stomach, following the major curve. The open edges are then attached together (often with surgical staples) to form a sleeve or tube with a banana shape.</description>
    <arm_group_label>Gastric sleeve</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        persons eligible for bariatric surgery in the Obesity policlinic, St Olavs Hospital,
        Trondheim, Norway
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  volunteers from Central Norway

          -  morbid obese BMI &gt; 40 kg/m2)

          -  morbid obese BMI &gt; 35 kg/m2 given a obesity related disease that qualifies for
             bariatric surgery

        Exclusion Criteria:

          -  previous or current alcohol abuse

          -  risk for alcohol harm as assessed by AUDIT

          -  alcohol abstinence

          -  liver disease except fatty liver, which occurs in more than 50% of those who seek
             bariatric surgery

          -  previous colon resection

          -  not/insufficiently able to informed consent

          -  drugs that interact with alcohol dehydrogenase

          -  drugs that slow down emptying of the stomach

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bård Kulseng, MD phd</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Magnus Strømmen, MSc</last_name>
    <phone>(+47) 9170 1010</phone>
    <email>magnus.strommen@stolav.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bård Kulseng, PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sykehuset Namsos</name>
      <address>
        <city>Namsos</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magnus Strømmen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Obesity policlinic of St. Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magnus Strømmen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Terez Stokkan</name>
      <address>
        <city>Trondheim</city>
        <zip>7000</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magnus Strømmen</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 12, 2014</lastchanged_date>
  <firstreceived_date>April 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bariatric surgery</keyword>
  <keyword>alcohol drinking</keyword>
  <keyword>alcoholism</keyword>
  <keyword>ethanol</keyword>
  <keyword>metabolism</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
